CJC-1296 + Ipamorelin

Description

This blend pairs CJC-1295, a modified growth hormone-releasing hormone (GHRH) analog with an extended half-life, with Ipamorelin, a selective growth hormone secretagogue peptide. Both compounds act on distinct but complementary points of the growth hormone release pathway, which makes the combination a common subject in laboratory research on the growth hormone axis. The formulation allows researchers to study the combined pharmacokinetic and signaling profile of the two peptides. Supplied as a lyophilized vial requiring reconstitution prior to laboratory use. This product is intended exclusively for laboratory research in controlled environments by qualified personnel. It is not a medication, carries no regulatory approval for human use, and is not intended for human consumption, therapeutic use, veterinary use, or cosmetic use. Handling, storage, and disposal should follow applicable laboratory biosafety guidelines.